Source:http://linkedlifedata.com/resource/pubmed/id/14870695
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-2-11
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1997-7298
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
54-6
|
pubmed:dateRevised |
2008-3-31
|
pubmed:meshHeading |
pubmed-meshheading:14870695-Antiparkinson Agents,
pubmed-meshheading:14870695-Dopamine Agonists,
pubmed-meshheading:14870695-Drug Therapy, Combination,
pubmed-meshheading:14870695-Humans,
pubmed-meshheading:14870695-Levodopa,
pubmed-meshheading:14870695-Parkinson Disease,
pubmed-meshheading:14870695-Piribedil
|
pubmed:year |
2004
|
pubmed:articleTitle |
[Treatment of Parkinson's disease: use of piribedil].
|
pubmed:publicationType |
Journal Article,
Review
|